Hims & Hers Super Bowl ad slams pricey pharma industry—and fumbles FDA warnings on compounded GLP-1 drugs
Taking a compounded GLP-1 medication isn’t the same thing as your pharmacy filling a cheaper, generic version of the drug ...
Meet ‘Super’ Ozempic: Higher Dose Semaglutide Leads to Even Greater Weight Loss In Major Trial
People who stayed on a 7.2 milligram weekly dose of semaglutide lost around 20% of their body weight over 72 weeks.
Business Insider on MSN14d
See ya, knock-off Ozempic
Lots of people are on cheaper compounded weight-loss drugs that mimic brands like Ozempic, Wegovy, and Zepbound. They're ...
Healthcare Dive19d
Medicare will negotiate Novo’s GLP-1 drug price. Here’s what that means for Ozempic, Wegovy.
Novo sells semaglutide as Ozempic, Rybelsus and Wegovy. The CMS will treat the different forms as a single product in price ...
Bellevue Reporter20d
The Science Behind GetSimpli Oral Tirzepatide: What Makes It So Effective?
GetSimpli Oral Tirzepatide is competitively priced, making it an accessible option for those seeking effective weight loss and metabolic health solutions. The regular price is $349.00, but first ...
Yahoo Finance27d
LLY Falls Around 14% in 3 Months: How to Play the Stock
Let’s understand the company’s strengths and weaknesses to better analyze how to play the stock after the price drop. Tirzepatide is a dual GIP and GLP-1 receptor agonist (GIP/GLP-1 RA).
Lexaria Bioscience price target lowered to $7 from $10 at H.C. Wainwright
H.C. Wainwright analyst Yi Chen lowered the firm’s price target on Lexaria Bioscience (LEXX) to $7 from $10 and keeps a Buy rating on the ...